Biomea Fusion Inc (BMEA)
4.50
-0.03
(-0.66%)
USD |
NASDAQ |
Jun 28, 16:00
4.42
-0.08
(-1.78%)
After-Hours: 20:00
Biomea Fusion SG&A Expense (TTM): 25.24M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 25.24M |
December 31, 2023 | 23.59M |
September 30, 2023 | 22.86M |
June 30, 2023 | 22.33M |
March 31, 2023 | 21.51M |
December 31, 2022 | 20.92M |
September 30, 2022 | 18.83M |
Date | Value |
---|---|
June 30, 2022 | 18.34M |
March 31, 2022 | 16.66M |
December 31, 2021 | 13.67M |
September 30, 2021 | 11.19M |
June 30, 2021 | 6.783M |
March 31, 2021 | 3.651M |
December 31, 2020 | 1.656M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
1.656M
Minimum
Dec 2020
25.24M
Maximum
Mar 2024
16.23M
Average
18.59M
Median
SG&A Expense (TTM) Benchmarks
Geron Corp | 83.31M |
Asensus Surgical Inc | 34.07M |
Geovax Labs Inc | 6.028M |
Syndax Pharmaceuticals Inc | 77.98M |
Cartesian Therapeutics Inc | 44.34M |